Hypokalemia, diabetes mellitus, and hypercortisolemia are the major contributing factors to cardiac dysfunction in adrenal Cushing's syndrome

Endocrine Journal

Volumn 56, Issue 8, 2009, Pages 1009-1018

  Takagi, Sachiko ^a   Tanabe, Akiyo ^a   Tsuiki, Mika ^a   Naruse, Mitsuhide ^b   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

Cardiac hypertrophy; Cortisol; Cushing's syndrome; Heart failure; Hypokalemia

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; POTASSIUM;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOKALEMIA; MALE; POTASSIUM BLOOD LEVEL; RISK ASSESSMENT;

ADULT; AGED; CUSHING SYNDROME; DIABETES COMPLICATIONS; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROCORTISONE; HYPOKALEMIA; MALE; MIDDLE AGED; POTASSIUM; PREVALENCE; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 73549108274     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-198     Document Type: Article

References (45)

1. Welbourn RB, Montgomery DA, Kennedy TL (1971) The natural history of treated Cushing's syndrome. Br J Surg 58: 1-16.
2. Welbourn RB (1985) Survival and causes of after adrenalectomy for Cushing's disease. Surgery 97: 16-20.
3. Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G (2004) High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf) 61: 768-777.
4. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88: 2527-2533.
5. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G (1999) Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84: 2664-2672.
6. Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol 40: 479-484.
7. Simon D, Goretzki PE, Lollert A, Röher HD (1993) Persistent hypertension after successful adrenal operation. Surgery 114: 1189-1195.
8. Tsuda K, Saikawa T, Yonemochi H, Maeda T, Shimoyama N, Hara M, Ito Y, Sakata T (1995) Electrocardiographic abnormalities in patients with Cushing's syndrome. Jpn Heart J 36: 333-339.
9. Sugihara N, Shimizu M, Kita Y, Shimizu K, Ino H, Miyamori I, Nakabayashi H, Takeda R (1992) Cardiac Characteristics and Postoperative Courses in Cushing's syndrome. Am J Cardiol 69: 75-1480.
10. Fallo F, Budano S, Sonino N, Muiesan ML, Agabiti-Rosei E, Boscaro M (1994) Left ventricular structural characteristics in Cushing's syndrome. J Hum Hypertens 8: 509-513.
11. Baykan M, Erem C, Gedikli O, Hacihasanoglu A, Erdogan T, Kocak M, Kaplan S, Kiriş A, Orem C, Celik S (2008) Assessment of left ventricular diastolic function and Tei index by tissue Doppler imaging in patients with Cushing's syndrome. Echocardiography 25: 182-190.
12. Petramala L, Battisti P, Lauri G, Palleschi L, Cotesta D, Iorio M, De Toma G, Sciomer S, Letizia C (2007) Cushing's syndrome patient who exhibited congestive heart failure. J Endocrinol Invest 30: 525-528.
13. Hersbach FM, Bravenboer B, Koolen JJ (2001) Hearty hormones. Lancet 11; 358 (9280): 468.
14. Younge PA, Shmidt D, Wiles PG (1995) Cushing's syndrome: still a potential killing disease. J R Soc Med 88: 174-175.
15. Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA, Mantero F, Fallo F (2003) Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol 41: 2275-2279.
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 26 (Suppl 1): S5-S20.
17. The International Expert Committee International expert committee report on the role of the AlC assay in the diagnosis of diabetes, Diabetes Care 2009: 321-6.
18. th edition, Little, Brown & Co, Boston, 1994.
19. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, Seki T, Demura R, Demura H (1997) Left ventricular hypertrophy is more prominent in patients with Primary Aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 20: 85-90.
20. Park SH, Shub C, Nobrega TP, Bailey KR, Seward JB (1996) Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: Correlations with autopsy and M-mode echocardiography. J Am Soc Echocardiogr 9: 119-128.
21. Arthur JL, Anthniy CP (1987) Evaluation of left ventricular diastolic function: clinical relevance and recent Doppler echocardiographic insights. Am Heart J 114: 836-851.
22. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL (2006) Systolic and Diastolic Heart Failure in the Community. JAMA 8: 2209-2216.
23. Richard BD, Nathaniel R (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613-618.
24. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345-352.
25. William BK, Albert JB (1991) Epidemiology of heart failure. Am Heart J 121: 951-957.
26. Tsuchihashi M, Tsutsui H, Kodama K, Kasagi F, Takeshita A (2000) Clinical characteristics and prognosis of hospitalized patients with congestive heart failure - a study in Fukuoka, Japan. Jpn Circ J 64: 953-959.
27. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation 10: 2668-2673.
28. Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA (2004) Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction (VALIANT) trial. Circulation 110: 1572-1578.
29. Karnik AA, Fields AV, Shannon RP (2007) Diabetic cardiomyopathy. Curr Hypertens Rep 6: 467-473.
30. Verdecchia P, Angeli F, Achilli P, Castellani C, Broccatelli A, Gattobigio R, Cavallini C (2007) Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events? Curr Opin Cardiol 22: 329-334.
31. Devereux RB, Roman MJ, Ganau A, de Simone G, Okin PM, Kligfield P (1994) Cardiac and arterial hypertrophy and atherosclerosis in hypertension. Hypertension 23: 802-809.
32. Sato A, Suzuki H, Murakami M, Nakazato Y, Iwaita Y, Saruta T (1994) Glucocorticoid increases angiotensin II type 1 receptor and Its gene expression. Hyperteneion 23: 25-30.
33. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G (2006) Characteristics of sudden death in hemodialysis patients. Kidney international 69: 2268-2273.
34. Khaw KT, Barrett-Connor E (1987) Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med 316: 235-240.
35. He FJ, MacGregor GA (2008) Beneficial effects of potassium on human health. Physiol Plant 133: 725-735.
36. Fisch C, Knoebel SB, Feigenbaum H, Greenspan K (1966) Potassium and the monophasic action potential, electrocardiogram, conduction and arrhythmias. Prog Cardiovasc Dis 8: 387-418.
37. Hasegawa J, Suyama Y, Kinugawa T, Morisawa T, Kishimoto Y (1998) Echocardiographic findings of the heart resembling dilated cardiomyopathy during hypokalemic myopathy due to licorice-induced pseudoaldosteronism. Cardiovasc Drugs Ther 12: 599-600.
38. Xie Z, Liu J, Malhotra D, Sheridan T, Periyasamy SM, Shapiro JI (2000) Effects of hypokalemia on cardiac growth. Ren Fail 22: 561-572.
39. Duprez D, De Buyzere M, Paelinck M, Rubens R, Dhooge W, Clement DL (1999) Relationship between left ventricular mass index and 24-h urinary free cortisol and cortisone in essential arterial hypertension. J Hypertens 17: 1583-1588.
40. Pirpiris M, Sudhir K, Yeung S, Jennings G, Whitworth JA (1992) Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension 19: 567-574.
41. Sudhir K, Jennings GL, Esler MD, Korner PI, Blombery PA, Lambert GW, Scoggins B, Whitworth JA (1989) Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function. Hypertension 13:416-421.
42. Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, Senba S (1986) Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab 62: 275-279.
43. Giraud GD, Louey S, Jonker S, Schultz J, Thornburg KL (2006) Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus. Endocrinology 147: 3643-3649.
44. Lumbers ER, Boyce AC, Joulianos G, Kumarasamy V, Barner E, Segar JL, Burrell JH (2005) Effects of cortisol on cardiac myocytes and on expression of cardiac genes in fetal sheep. Am J Physiol Regul Integr Comp Physiol 288:R567-574.
45. Bonnin R, Villabona C, Rivera A, Guillen E, Sagarra E, Soler J, Navarro MA (1993) Is salivary cortisol a better index than free cortisol in serum or urine for diagnosis of Cushing syndrome? Clin Chem 39: 1353-1354.